, the agrichemical giant has joined forces with Pairwise Plants – a California start-up company helmed by a pair of Harvard scientists – and plans to invest a whopping $100 million in a form of gene-editing technology.
While the new technology, known as CRISPR, is being hailed by some as a way to correct genetic diseases, many natural health advocates question its safety – and whether our food is an appropriate target for gene-editing.
Three days after the collaboration was announced, a published study showing that CRISPR induced unexpected mutations in mice was retracted. The timing is highly suspicious, to say the …read more
Source: Natural Health 365
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr